The global rickets market is profoundly impacted by the prevalence of vitamin D and calcium deficiencies. Lack of adequate sunlight exposure, a primary source of vitamin D, alongside limited dietary intake of nutrient-rich foods such as oily fish and eggs, contributes to the condition's widespread occurrence. The market's trajectory is shaped by the imperative to combat these deficiencies, emphasizing education, awareness, and interventions. As healthcare systems strive to ensure strong and healthy bone development in children, the demand for effective solutions propels growth in the global rickets market.
According to Data Bridge Market Research, the Global Rickets Market is growing at a CAGR of 9.10% in the forecast period of 2022-2029.
“Leading junk or fast food industry facilitate market growth”
The leading junk or fast food industry acts as a driver of the global rickets market. The widespread availability and consumption of such foods, rich in unhealthy fats, sugars, and low nutritional value, contribute to poor dietary habits. These diets often lack essential vitamins and minerals vital for bone health, exacerbating the risk of rickets. As the fast food industry continues to thrive globally, the prevalence of nutritional deficiencies rises, necessitating increased awareness, education, and interventions to mitigate the impact on bone health and the overall rickets market.
What restraints the growth of the global rickets market?
“High cost of drugs and supplements”
The high cost of drugs and supplements serves as a significant restraint in the global rickets market. Affordability issues limit access to essential medications and nutritional supplements required for rickets treatment and prevention. This impediment particularly affects individuals from lower-income backgrounds, leading to inadequate management of the condition. The financial burden hampers effective healthcare delivery and exacerbates the prevalence of rickets, highlighting the need for accessible and cost-effective solutions to ensure optimal care for affected populations.
Segmentation: Global Rickets Market
The rickets market is segmented on the basis of type, causes, therapy, and end users.
- On the basis of type, the rickets market is segmented into vitamin D-related rickets, hypocalcemia-related rickets, hypophosphatemia-related rickets
- On the basis of causes, the rickets market is segmented into sunlight, diet, genetics, and others.
- On the basis of therapy, the rickets market is segmented into is segmented into diagnosis and treatment
- On the basis of end users, the rickets market is divided into hospital, clinics, and others.
Regional Insights: North America dominates the Global Rickets Market
North America holds a commanding position in the rickets market in both market share and revenue, with this dominance projected to persist through the forecast period. This stronghold can be attributed to the region's well-established healthcare sector and the growing demand for vitamin supplements. The healthcare infrastructure's advancement and the population's inclination towards vitamin supplementation contribute to North America's continued dominance.
Contrastingly, the Asia-Pacific (APAC) region is anticipated to exhibit the highest growth rate in the rickets market during the forecast period. APAC benefits from a substantial patient population and consistently developing economies. This combination positions the region for robust growth as it addresses the healthcare needs of its expanding populace while experiencing economic progress.
To know more about the study visit, https://www.databridgemarketresearch.com/reports/global-rickets-market
The Prominent Key Players Operating in the Global Rickets Market Include:
- Koninklijke DSM N.V.(Netherlands)
- Pfizer Inc. (U.S.)
- Sanofi (France)
- GlaxoSmithKline plc (U.K.)
- AARTI INDUSTRIES LIMITED (India)
- Recipharm AB (Sweden)
- Jubilant Pharmova Limited (India)
- LUPIN (India)
- Aurobindo Pharma (India)
- Alembic Pharmaceuticals Limited (India)
- Nestlé (Switzerland)
- ADM (Archer Daniels Midland Company) (U.S.)
- Groupe Danone S.A. (France)
- Abbott (U.S.)
- Kraft Foods Group, Inc. (U.S.)
- Trivedi Global Inc. (U.S.)
- Merck & Co., Inc. (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Sun Pharmaceutical Industries Ltd (India)
Above are the key players covered in the report, to know about more and exhaustive list of global rickets market companies contact, https://www.databridgemarketresearch.com/contact
Research Methodology: Global Rickets Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
